Global Central Nervous System Therapeutic Market Size & Outlook

The central nervous system therapeutic industry worldwide is expected to reach a projected revenue of US$ 203,559.2 million by 2030. A compound annual growth rate of 7.7% is expected of the worldwide central nervous system therapeutic industry from 2025 to 2030.
Revenue, 2024 (US$M)
$130,154.6
Forecast, 2030 (US$M)
$203,559.2
CAGR, 2025 - 2030
7.7%
Report Coverage
Worldwide

Global central nervous system therapeutic market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Global central nervous system therapeutic market highlights

  • The global central nervous system therapeutic market generated a revenue of USD 116,249.4 million in 2024 and is expected to reach USD 178,896.8 million by 2030.
  • The market is expected to grow at a CAGR (2025 - 2030) of 7.4% by 2030.
  • In terms of segment, mental health accounted for a revenue of USD 44,442.9 million in 2024.
  • Neurodegenerative Diseases is the most lucrative disease segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2024.
  • Country-wise, India is expected to register the highest CAGR from 2025 to 2030.

Global data book summary

Market revenue in 2024USD 116,249.4 million
Market revenue in 2030USD 178,896.8 million
Growth rate7.4% (CAGR from 2025 to 2030)
Largest segmentMental health
Fastest growing segmentNeurodegenerative Diseases
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationNeurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Diseases, CNS Cancer

Other key industry trends

  • In terms of revenue, the North America accounted for 41.9% of the global central nervous system therapeutic market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, India is the fastest growing regional market and is projected to reach USD 1,863.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Central Nervous System Therapeutic Market Companies

Name Profile # Employees HQ Website

Global central nervous system therapeutic market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central nervous system therapeutic market will help companies and investors design strategic landscapes.


Mental health was the largest segment with a revenue share of 38.23% in 2024. Horizon Databook has segmented the Global central nervous system therapeutic market based on neurovascular diseases, cns trauma, mental health, neurodegenerative diseases, infectious diseases, cns cancer covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Central Nervous System Therapeutic Disease Outlook (Revenue, USD Million, 2018-2030)
    • Neurovascular Diseases
    • CNS Trauma
    • Mental Health
      • Anxiety Disorders
      • Epilepsy
      • Mood Disorders
      • Psychotic Disorders
      • Others
    • Neurodegenerative Diseases
      • Alzheimers Disease
      • Parkinsosns Disease
      • Multiple Sclerosis
      • Huntingtons Disease
      • Amytrophic Lateral Sclerosis
      • Others
    • Infectious Diseases
    • CNS Cancer
    • Others
  • Global Central Nervous System Therapeutic Drug Class Outlook (Revenue, USD Million, 2018-2030)
    • Antidepressants
    • Antipsychotics
    • Antiepileptics (AEDs)
    • Dopaminergic Agents
    • Neuroprotective Agents
    • Immunomodulators
    • Others
  • Global Central Nervous System Therapeutic Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Others

Reasons to subscribe to Global central nervous system therapeutic market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global central nervous system therapeutic market databook

  • Our clientele includes a mix of central nervous system therapeutic market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global central nervous system therapeutic market , including forecasts for subscribers. This global databook contains high-level insights into Global central nervous system therapeutic market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global central nervous system therapeutic market size, by regions, 2018-2030 (US$M)

Top 10 countries: Central nervous system therapeutic market size, 2024 (US$M)

Global central nervous system therapeutic market share, by disease, 2024 & 2030 (%, US$M)

Central nervous system therapeutic market: Opportunity assessment by country

Global central nervous system therapeutic market, by region, 2024 (US$M)

Global central nervous system therapeutic market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more